En undersøgelse omfattede 1111 voksne og en anden 82 patienter mellem to og 17 år.
For the empirical treatment of neutropenic febrile patients, Cancidas has been compared with amphotericin B in two studies: one involving 1,111 adults and another involving 82 patients aged between two and 17 years.